Evofem Biosciences (EVFM) Competitors $0.0088 0.00 (-3.30%) As of 04/30/2025 03:49 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsSustainabilityTrendsBuy This Stock EVFM vs. SBFM, RDHL, MBIO, PWUP, INM, CDT, VRAX, KZIA, GLTO, and PPBTShould you be buying Evofem Biosciences stock or one of its competitors? The main competitors of Evofem Biosciences include Sunshine Biopharma (SBFM), RedHill Biopharma (RDHL), Mustang Bio (MBIO), PowerUp Acquisition (PWUP), InMed Pharmaceuticals (INM), Conduit Pharmaceuticals (CDT), Virax Biolabs Group (VRAX), Kazia Therapeutics (KZIA), Galecto (GLTO), and Purple Biotech (PPBT). These companies are all part of the "pharmaceutical products" industry. Evofem Biosciences vs. Sunshine Biopharma RedHill Biopharma Mustang Bio PowerUp Acquisition InMed Pharmaceuticals Conduit Pharmaceuticals Virax Biolabs Group Kazia Therapeutics Galecto Purple Biotech Evofem Biosciences (NASDAQ:EVFM) and Sunshine Biopharma (NASDAQ:SBFM) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, valuation, institutional ownership, profitability, analyst recommendations and community ranking. Which has more volatility & risk, EVFM or SBFM? Evofem Biosciences has a beta of -0.87, indicating that its share price is 187% less volatile than the S&P 500. Comparatively, Sunshine Biopharma has a beta of 1.32, indicating that its share price is 32% more volatile than the S&P 500. Do analysts recommend EVFM or SBFM? Sunshine Biopharma has a consensus target price of $15.00, suggesting a potential upside of 1,011.11%. Given Sunshine Biopharma's stronger consensus rating and higher possible upside, analysts clearly believe Sunshine Biopharma is more favorable than Evofem Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Evofem Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Sunshine Biopharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is EVFM or SBFM more profitable? Sunshine Biopharma has a net margin of -12.82% compared to Evofem Biosciences' net margin of -46.42%. Sunshine Biopharma's return on equity of -17.89% beat Evofem Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Evofem Biosciences-46.42% -91.97% -61.93% Sunshine Biopharma -12.82%-17.89%-14.25% Does the MarketBeat Community prefer EVFM or SBFM? Evofem Biosciences received 260 more outperform votes than Sunshine Biopharma when rated by MarketBeat users. However, 100.00% of users gave Sunshine Biopharma an outperform vote while only 69.50% of users gave Evofem Biosciences an outperform vote. CompanyUnderperformOutperformEvofem BiosciencesOutperform Votes26269.50% Underperform Votes11530.50% Sunshine BiopharmaOutperform Votes2100.00% Underperform VotesNo Votes Which has higher earnings and valuation, EVFM or SBFM? Evofem Biosciences has higher earnings, but lower revenue than Sunshine Biopharma. Evofem Biosciences is trading at a lower price-to-earnings ratio than Sunshine Biopharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEvofem Biosciences$11.39M0.09$52.98M-$0.21-0.04Sunshine Biopharma$34.87M0.10-$4.51M-$150.88-0.01 Do insiders & institutionals believe in EVFM or SBFM? 0.2% of Evofem Biosciences shares are owned by institutional investors. Comparatively, 42.0% of Sunshine Biopharma shares are owned by institutional investors. 0.2% of Evofem Biosciences shares are owned by company insiders. Comparatively, 0.1% of Sunshine Biopharma shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media refer more to EVFM or SBFM? In the previous week, Sunshine Biopharma had 1 more articles in the media than Evofem Biosciences. MarketBeat recorded 1 mentions for Sunshine Biopharma and 0 mentions for Evofem Biosciences. Sunshine Biopharma's average media sentiment score of 1.91 beat Evofem Biosciences' score of 0.00 indicating that Sunshine Biopharma is being referred to more favorably in the news media. Company Overall Sentiment Evofem Biosciences Neutral Sunshine Biopharma Very Positive SummarySunshine Biopharma beats Evofem Biosciences on 14 of the 18 factors compared between the two stocks. Get Evofem Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EVFM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EVFM vs. The Competition Export to ExcelMetricEvofem BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$998,000.00$6.89B$5.56B$7.83BDividend YieldN/A3.05%5.11%4.22%P/E Ratio-0.017.4422.4818.48Price / Sales0.09242.70395.93103.60Price / CashN/A65.8538.1834.62Price / Book0.006.516.774.25Net Income$52.98M$143.21M$3.22B$248.23M7 Day PerformanceN/A1.98%1.47%0.89%1 Month PerformanceN/A6.89%3.99%3.53%1 Year PerformanceN/A-2.52%16.15%5.08% Evofem Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EVFMEvofem BiosciencesN/A$0.01-3.3%N/A-37.1%$998,000.00$11.39M-0.01120Gap DownSBFMSunshine Biopharma3.2076 of 5 stars$1.44-4.6%$15.00+941.7%+54.3%$3.90M$34.87M-0.013Negative NewsGap UpRDHLRedHill Biopharma1.0685 of 5 stars$2.17-10.0%N/A-99.2%$3.84M$8.04M0.00210Analyst ForecastGap DownMBIOMustang Bio2.6019 of 5 stars$1.16-4.9%$100.00+8,520.7%-91.2%$3.84MN/A-0.01100Positive NewsPWUPPowerUp AcquisitionN/A$0.49-4.0%N/AN/A$3.78MN/A0.00N/AGap UpHigh Trading VolumeINMInMed Pharmaceuticals0.2762 of 5 stars$3.01+0.7%N/A-44.6%$3.63M$4.83M-0.2210Short Interest ↑Negative NewsCDTConduit Pharmaceuticals0.342 of 5 stars$0.55-3.1%N/A-99.8%$3.63MN/A-0.013Short Interest ↑Gap DownVRAXVirax Biolabs Group2.3842 of 5 stars$1.11+5.7%$3.00+170.3%+55.6%$3.59M$84,872.000.005Short Interest ↑Gap UpKZIAKazia Therapeutics3.7785 of 5 stars$3.56-2.2%$57.50+1,515.2%-78.6%$3.59M$2.31M0.0012Positive NewsGLTOGalecto3.1118 of 5 stars$2.68-7.6%$10.00+273.1%-83.7%$3.54MN/A-0.1440Upcoming EarningsPositive NewsHigh Trading VolumePPBTPurple Biotech2.7131 of 5 stars$2.65-1.9%$33.00+1,145.3%N/A$3.53MN/A-0.3020News CoveragePositive NewsGap DownHigh Trading Volume Related Companies and Tools Related Companies Sunshine Biopharma Alternatives RedHill Biopharma Alternatives Mustang Bio Alternatives PowerUp Acquisition Alternatives InMed Pharmaceuticals Alternatives Conduit Pharmaceuticals Alternatives Virax Biolabs Group Alternatives Kazia Therapeutics Alternatives Galecto Alternatives Purple Biotech Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:EVFM) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evofem Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evofem Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EVFM Stock Free EVFM Stock Alerts